Xtant Medical Holdings (XTNT) Cost of Revenue (2010 - 2025)
Xtant Medical Holdings (XTNT) posted quarterly Cost of Revenue of $11.3 million for Q3 2025, down 3.16% year-over-year from $11.6 million in Q3 2024, and up 1.22% quarter-over-quarter from $11.1 million in Q2 2025.
Xtant Medical Holdings (XTNT) Cost of Revenue (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Cost of Revenue for 16 consecutive years, with $11.3 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Cost of Revenue fell 3.16% year-over-year to $11.3 million; the TTM figure through Sep 2025 stood at $50.5 million (up 13.49% YoY), while the FY2024 annual figure was $49.1 million, up 36.88% from the prior year.
- Cost of Revenue climbed to $11.3 million in Q3 2025 per XTNT's latest filing, from $11.1 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $15.5 million in Q4 2024 and bottomed at $4.5 million in Q1 2021.
- Historically, Cost of Revenue has averaged $8.9 million across 5 years, with a median of $7.8 million in 2023.
- Annual changes were most pronounced in 2021 — Cost of Revenue declined 13.82% — and 2023, when it surged 57.54%.
- Xtant Medical Holdings' Cost of Revenue stood at $6.3 million in 2021, then advanced by 10.98% to $7.0 million in 2022, then soared by 57.54% to $11.0 million in 2023, then surged by 41.18% to $15.5 million in 2024, then retreated by 27.28% to $11.3 million in 2025.
- Business Quant data shows XTNT's Cost of Revenue at $11.3 million in Q3 2025, $11.1 million in Q2 2025, and $12.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Xtant Medical Holdings | 46.73 Mn | 29.13 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 11.26 Mn |
| Sep 30, 2025 | 11.26 Mn |
| Jun 30, 2025 | 11.13 Mn |
| Jun 30, 2025 | 11.13 Mn |
| Mar 31, 2025 | 12.66 Mn |
| Mar 31, 2025 | 12.66 Mn |
| Dec 31, 2024 | 15.49 Mn |
| Dec 31, 2024 | 15.49 Mn |
| Sep 30, 2024 | 11.63 Mn |
| Sep 30, 2024 | 11.63 Mn |
| Jun 30, 2024 | 11.36 Mn |
| Jun 30, 2024 | 11.36 Mn |
| Mar 31, 2024 | 10.57 Mn |
| Mar 31, 2024 | 10.57 Mn |
| Dec 31, 2023 | 10.97 Mn |
| Dec 31, 2023 | 10.97 Mn |
| Sep 30, 2023 | 9.69 Mn |
| Sep 30, 2023 | 9.69 Mn |
| Jun 30, 2023 | 7.77 Mn |
| Jun 30, 2023 | 7.77 Mn |